Total Funding
53
66
Total FundingPost-IPO Equity raised
Growth Score 53 in past quarter
-2 pts
Heat Score 66 in past quarter
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
208660
Moberg Derma rapidly growing Swedish pharmaceutical company that commercializes proprietary, acquired and licensed products.
About the Company
Moberg Pharma is a rapidly growing Swedish pharmaceutical company that commercializes proprietary, acquired and licensed products in the global market.
They create value for patients, physicians and owners by offering products based on proven compounds, which have better efficacy, fewer side effects or are easier to use. Initially, Moberg
Pharma specialized in the treatment of skin diseases but is now widening its scope to include additional areas. They market OTC brands in the U.S. and sell through distributors in more than 35 countries.
